Živić, K.; Pavlović, M.; Ostojić, M.; Galun, D.; Pavić, A.; Srdić-Rajić, T.; Grahovac, J.
Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma. Cells 2026, 15, 1032.
https://doi.org/10.3390/cells15111032
AMA Style
Živić K, Pavlović M, Ostojić M, Galun D, Pavić A, Srdić-Rajić T, Grahovac J.
Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma. Cells. 2026; 15(11):1032.
https://doi.org/10.3390/cells15111032
Chicago/Turabian Style
Živić, Kristina, Marijana Pavlović, Marija Ostojić, Danijel Galun, Aleksandar Pavić, Tatjana Srdić-Rajić, and Jelena Grahovac.
2026. "Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma" Cells 15, no. 11: 1032.
https://doi.org/10.3390/cells15111032
APA Style
Živić, K., Pavlović, M., Ostojić, M., Galun, D., Pavić, A., Srdić-Rajić, T., & Grahovac, J.
(2026). Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma. Cells, 15(11), 1032.
https://doi.org/10.3390/cells15111032
